Strekin AG Publishes Data on Drug to Treat Sensorineural Hearing Loss

The paper “Pioglitazone represents an effective therapeutic target in preventing oxidative/inflammatory cochlear damage induced by noise exposure” was published in “Frontiers in Pharmacology.”